High-level expression of microRNA-21 in peripheral blood mononuclear cells is a diagnostic and prognostic marker in prostate cancer

W Huang, XL Kang, S Cen, Y Wang… - Genetic testing and …, 2015 - liebertpub.com
Aims: Our study aimed to evaluate the diagnostic and prognostic values of microRNA-21
(miR-21) expression levels in peripheral blood mononuclear cells (PBMCs) for prostate …

MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer

B Yang, Z Liu, H Ning, K Zhang, D Pan… - Cancer …, 2016 - content.iospress.com
OBJECTIVE: To evaluate the effects of microRNA-21 (miR-21) in peripheral blood
mononuclear cells (PBMC) in the diagnosis and prognosis of prostate cancer (PCa) …

High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients

MJ Stoen, S Andersen, M Rakaee, MI Pedersen… - Scientific reports, 2021 - nature.com
MicroRNAs (miRs) are small non-coding RNA molecules, which are involved in the
development of various malignancies, including prostate cancer (PCa). miR-17-5p is …

Prognostic value of microRNA-20b expression level in patients with prostate cancer

R Zhang, F Li, Y Wang, M Yao, C Chi - 2020 - digitum.um.es
Background. miR-20b is a member of the miR-106a-363 gene cluster located in the
mammalian X chromosome, the larger miR-17 family, and the miR-17-92 and miR-106b-25 …

Increased oncogenic microRNA-18a expression in the peripheral blood of patients with prostate cancer: A potential novel non-invasive biomarker

G Al‑Kafaji, ZT Al-Naieb, M Bakhiet - Oncology Letters, 2016 - spandidos-publications.com
MicroRNAs have been demonstrated to be stably detectable in peripheral blood, thus
representing important sources of non-invasive biomarkers of various diseases, including …

MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer

X Ling, Z Han, D Xia, H He, F Jiang, Z Lin, X Fu… - Molecular biology …, 2014 - Springer
Abstract MicroRNA-30c (miR-30c) acts as a tumor suppressor or a tumor promoter in various
human malignancies. However, the involvement of miR-30c in prostate cancer (PCa) is still …

Association of microRNA‐21 expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen …

Y Guan, Y Wu, Y Liu, J Ni, S Nong - The Prostate, 2016 - Wiley Online Library
BACKGROUND Despite androgen deprivation therapy (ADT) remains the mainstay therapy
for advanced prostate cancer (PCa), the patients have widely variable durations of response …

Overexpression of mir-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer—A multi-institutional study

MJ Stoen, S Andersen, M Rakaee, MI Pedersen… - Cancers, 2021 - mdpi.com
Simple Summary MicroRNAs (miRs) have critical regulatory roles in cell functions, and are
involved in prostate cancer tumorigenesis. miR-20a-5p is a member of the oncogenic miR …

[HTML][HTML] The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer

Y Goto, S Kojima, R Nishikawa, H Enokida… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Our recent study of microRNA (miRNA) expression signatures in prostate cancer (PCa) has
revealed that all members of the miR-23b/27b/24-1 cluster are significantly downregulated …

[HTML][HTML] The clinical significance of circulating miR-21, miR-142, miR-143, and miR-146a in patients with prostate cancer

IM Bolayırlı, B Önal, M Adıgüzel… - Journal of Medical …, 2022 - ncbi.nlm.nih.gov
Background Prostate cancer (PCa) is the most common type of solid tissue cancer among
men in western countries. In this study, we determined the levels of circulating miR-21, miR …